Location History:
- Yunnan, CN (2018 - 2019)
- Kunming, CN (2020)
Company Filing History:
4 out of 4 
1 out of 3 Years Active: 2018-2025
Title: Innovations and Contributions of Inventor Mingyi Wu
Introduction
Mingyi Wu is a notable inventor based in Yunnan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit thrombotic diseases. With a total of four patents to his name, his work has garnered attention in the scientific community.
Latest Patents
Mingyi Wu's latest patents include an oligosaccharide compound designed to inhibit the intrinsic coagulation factor X-enzyme complex. This invention features a purified oligosaccharide compound with antithrombotic activity, along with a preparation method and various uses. The compound serves as an intrinsic factor X-enzyme inhibitor, which is crucial in the development of drugs aimed at preventing and treating thrombotic diseases. Another significant patent involves a Fuc3S4S substituted oligoglycosaminoglycan, which has a weight-average molecular weight of approximately 4.5-9 kD. This invention also includes a pharmaceutical composition and preparation method, emphasizing its application in medicines for thrombotic disease prevention and treatment.
Career Highlights
Throughout his career, Mingyi Wu has worked with prominent companies in the pharmaceutical industry, including Jiuzhitang Co., Ltd. and Mudanjiang Youbo Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to innovative solutions in medicine.
Collaborations
Mingyi Wu has collaborated with several professionals in his field, including Jinhua Zhao and Na Gao. These partnerships have facilitated the exchange of ideas and advancements in their shared research interests.
Conclusion
Mingyi Wu's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work in developing compounds for thrombotic disease treatment showcases the importance of research and collaboration in achieving significant breakthroughs.